Serial medtech entrepreneur Dale Spencer died last week in Scottsdale, Ariz, according to the Medical Alley Association. Spencer helped found more than a dozen medical device companies, including SciMed, eV3, EndoMetabolic Solutions, ConcepTx Medical and Anulex Technologies. He also served on the boards of Boston Scientific (NYSE:BSX), Micro Therapeutics, Northstar Neuroscience, Spine Wave, Vertis Neuroscience, Velocimed […]
Endo Health
Court quashes American Medical Systems subpoenas in pelvic mesh case, to mull sanctions
The federal court overseeing the multidistrict litigation over pelvic mesh products made by American Medical Systems, the erstwhile women’s health business once owned by Endo International (NSDQ:ENDP), is mulling sanctions on the company after quashing a 2nd round of subpoenas sent to an outside witness. Endo, which acquired AMS in 2011 for $2.9 billion, in 2015 dealt the men’s […]
Analogic CEO Green steps away | Personnel Moves Nov 4, 2016
Analogic (NSDQ:ALOG) said late last month its prez and CEO James Green has stepped away from his position to pursue other opportunities. Company director and former Enovate Medical exec chair and CEO Dr. Fred Parks has been named to take over Green’s position. “Jim Green led Analogic during a period of meaningful development and growth, and […]
Endo’s AMS claims pelvic mesh plaintiffs scammed into needless explantation surgeries
Endo International (NSDQ:ENDP) subsidiary American Medical Systems Holdings reportedly accused “a pyramid of businessmen, doctors and lawyers” of convincing women to undergo unnecessary surgeries to remove pelvic mesh implants and inflate their damage claims. AMS has set aside $1.9 billion to cover as many as 49,000 product liability lawsuits alleging injury from the devices. But the company […]
Endo tumbles on plans to shutter Astora biz
Endo Health Solutions (NSDQ:ENDP) saw shares drop 20% today after announcing plans to close its Astora Women’s Health biz in March due to concerns over future product liability related to mesh implants, despite posting a solid earnings beat for Q4 and the full year 2015. The company, along with other medical device makers, have been hit with […]
Jury adds $7 million in punitive damages to Johnson & Johnson’s $5.5m mesh loss
Johnson & Johnson (NYSE:JNJ) must pay $7 million in punitive damages on top of $5.5 million in compensatory damages it was ordered to pay yesterday in the 1st of a series of pelvic mesh lawsuits. Jurors took 2 hours of deliberation before they reached the $7 million figure, according to Law360.com. Johnson & Johnson and its Ethicon […]
Johnson & Johnson lose 1st Philly mesh case
A jury in Philadelphia ruled today that Johnson & Johnson (NYSE:JNJ) must pay $5.5 million in the 1st in a series of pelvic mesh lawsuits. The jury found J&J liable, based on the negligence of its scientists in relation to its Prolift pelvic mesh implant, citing it as the root cause of plaintiff Patricia Hammons’ […]
FDA OKs Endo’s opioid cheek patch licensed from BioDelivery Sciences
(Reuters) — BioDelivery Sciences International said the FDA approved its opioid cheek patch for chronic pain, sending the drugmaker’s shares up 23% in premarket trading today. Endo International (NSDQ:ENDP) licensed the worldwide manufacturing and marketing rights to the treatment, Belbuca, from BioDelivery in 2012. Belbuca is an opioid film patch and aims to treat patients with […]
Endo reports Q2 beat on rev, earnings
Endo Health Solutions (NSDQ:ENDP) reported 2nd quarter earnings today that beat expectations for revenue and earnings per share by a fair margin while continuing its acquisition plans for Par Pharmaceuticals. Endo International reported losses of $250.5 million, or $1.35 per share, on sales of $735.2 million for the 3 months ended June 30. Adjusted to […]
Endo sheds assets from Litha subsidiary
Endo International (NSDQ:ENDP) said yesterday it is selling off certain assets from its South Africa-based Litha Healthcare subsidiary. The assets, a portfolio of device, vaccine and non-core products, are being acquired by a consortium comprised of Westrate Trade, Invest Proprietary Limited and Immunotek Limited, according to the company. The Dublin, Ireland-based company said they expect […]
Boston Scientific closes $1.6B Endo urology portfolio buy
Boston Scientific (NYSE:BSX) said today it closed its $1.6 billion acquisition of the Endo Health Solutions (NSDQ:ENDP) owned American Medical Systems urology portfolio, including its men’s health and prostate health businesses. The deal consists of a $1.6 billion up-front payment and a potential $50 million milestone payment based on 2016 sales, according to the companies. “This […]
